Literature DB >> 3097125

Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells.

J J Mond, J Carman, C Sarma, J Ohara, F D Finkelman.   

Abstract

The data presented in this manuscript extend our previous observations that recombinant interferon-gamma (reIFN-gamma) can suppress anti-immunoglobulin (anti-Ig)-stimulated B cell proliferation, and demonstrate that reIFN-gamma can also suppress B cell stimulation factor type 1 (BSF-1)-stimulated increases in expression of MHC class II molecules (Ia) on B cells. This suppression is most effective when relatively low concentrations of BSF-1 are employed, but is still very substantial even when optimal concentrations of BSF-1 were used. This suppression is also observed when size-separated small B cells which are devoid of detectable macrophages or NK cells are cultured with BSF-1 and reIFN-gamma, thus suggesting that IFN-gamma-mediated inhibition is a consequence of a direct effect on the B cells. Incubation of B cells with reIFN-gamma for 24 hr before their culture with BSF-1 did not prevent BSF-1-stimulated increases in sIa. This finding supports the contention that the effect of IFN-gamma is not mediated via the stimulation of "suppressor" influences in these cell cultures. The inhibition of B cell activation by IFN-gamma occurs within the first 3 hr after the onset of culture, as demonstrated by the inability of antibody to IFN-gamma to totally reverse the IFN-gamma-mediated suppressive effects on B cell proliferation if it is added later than 3 hr after the onset of culture. These results suggest a role for IFN-gamma in down-regulating the ability of B cells to function as antigen-presenting cells in non-cognate T cell-dependent responses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097125

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Low affinity IgE receptors (Fc epsilon RII).

Authors:  D H Conrad
Journal:  Clin Rev Allergy       Date:  1989

2.  Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome.

Authors:  S Plaeger-Marshall; A Haas; L T Clement; J V Giorgi; I S Chen; S G Quan; R A Gatti; E R Stiehm
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

3.  B cell growth factor activity in supernatants of MRL-lpr/lpr derived T cell hybridomas.

Authors:  U Schauer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

4.  Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma.

Authors:  E M Lemmel; D Brackertz; M Franke; W Gaus; P W Hartl; K Machalke; H Mielke; H J Obert; H H Peter; J Sieper
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes.

Authors:  C R Hume; R S Accolla; J S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 6.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

Review 7.  The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses.

Authors:  A Jurado; J Carballido; H Griffel; H K Hochkeppel; G D Wetzel
Journal:  Experientia       Date:  1989-06-15

8.  Examination of the inhibitory effects of interferon-gamma on interleukin-4-induced stimulation of resting B cells from NZB/NZW F1 mice.

Authors:  M Minoda; K Hamada; M Higashikawa; H Sugishima; M Funauchi; A Horiuchi
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

9.  Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Immunity to Trichinella spiralis infection in vitamin A-deficient mice.

Authors:  J A Carman; L Pond; F Nashold; D L Wassom; C E Hayes
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.